|
Volumn 98, Issue 4, 2006, Pages 535-537
|
Comparison of a Single End Point to Determine Optimal Initial Warfarin Dosing (5 mg Versus 10 mg) for Venous Thromboembolism
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FONDAPARINUX;
WARFARIN;
ACUTE DISEASE;
ADULT;
AGED;
ARTICLE;
BLEEDING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
FEMALE;
FOLLOW UP;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LABORATORY TEST;
MALE;
OPTIMAL DRUG DOSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
VENOUS THROMBOEMBOLISM;
ACUTE DISEASE;
ANTICOAGULANTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FACTOR X;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
POLYSACCHARIDES;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
WARFARIN;
|
EID: 33746779382
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2006.02.063 Document Type: Article |
Times cited : (22)
|
References (5)
|